Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00456144 · ClinicalTrials.gov registry record
Prospective Observation Study of Insulin Sensitivity During and After Gonadotropin Releasing Hormone Agonist Therapy for Prostate Cancer
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 36
- Enrollment target
NCT00456144: Completed study, sponsored by Massachusetts General Hospital.
NCT00456144 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00456144 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
The purpose of this research study is to find out if a certain type of hormone therapy, gonadotropin-releasing hormone agonist (GnRH agonist), affects the way the body produces and responds to insulin. The investigators will evaluate the changes in insulin sensitivity during and after GnRH agonist treatment for prostate cancer. The investigators are assessing the possibility that treatment-related insulin resistance may contribute to the risk of diabetes and/or cardiovascular disease in men with prostate cancer.
Interventions
- DRUG Gonadotropin Releasing Hormone Agonist Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2006-08 |
| Est. Completion | 2012-09 |
What the finished NCT00456144 record still lists
NCT00456144 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 36 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Gonadotropin Releasing Hormone Agonist Therapy is the first listed.
NCT00456144 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00456144 about?
NCT00456144 is a clinical study titled "Prospective Observation Study of Insulin Sensitivity During and After Gonadotropin Releasing Hormone Agonist Therapy for Prostate Cancer". The purpose of this research study is to find out if a certain type of hormone therapy, gonadotropin-releasing hormone agonist (GnRH agonist), affects the way the body produces and responds to insulin. The investigators will evaluate the changes in insulin sensitivity during and after GnRH agonist t...
What is the current status of trial NCT00456144?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2006-08. Estimated completion is 2012-09.
What interventions are being tested in trial NCT00456144?
The interventions under investigation include: Gonadotropin Releasing Hormone Agonist Therapy (DRUG).
Who is sponsoring clinical trial NCT00456144?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia